EMBL Ventures
Overview
EMBL Ventures is an early stage venture capital investor currently managing investments on behalf of major institutional investors in Europe. EMBL Ventures invests in core technologies with global potential and is focused on life-science investments, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics. Healthcare focused
Investment Focus
- Lead or co-lead investment role
- Focus on early-stage life science companies
- Investment size between €5 million and €40 million
Portfolio Companies
Reach EMBL Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about EMBL Ventures
What sectors does EMBL Ventures invest in?
EMBL Ventures invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Heidelberg, Germany. EMBL Ventures is listed as a vc in the ConnectSafely investor database.
What stage does EMBL Ventures invest at?
EMBL Ventures backs companies at Early Stage, Series A and Series B, writing cheques of 5M - 40M.
Which regions does EMBL Ventures invest in?
EMBL Ventures invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
What companies has EMBL Ventures invested in?
EMBL Ventures's portfolio includes ViraTherapeutics and Luxendo.
How do I contact EMBL Ventures?
EMBL Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
